{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:28:52Z","timestamp":1783524532526,"version":"3.55.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fund for Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018215","name":"R\u00e9gion de Bruxelles-Capitale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018215","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004744","name":"Innoviris","doi-asserted-by":"publisher","award":["2023-BFB-1"],"award-info":[{"award-number":["2023-BFB-1"]}],"id":[{"id":"10.13039\/501100004744","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Laboratory Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.plabm.2025.e00508","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:25:51Z","timestamp":1760142351000},"page":"e00508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Towards the clinical use of peripheral bile acids: Recommendations to limit their preanalytical and analytical sources of variability"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5341-6363","authenticated-orcid":false,"given":"Sebastian","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"de Buyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle A.","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Serafimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Feron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-482X","authenticated-orcid":false,"given":"Laure-Alix","family":"Clerbaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plabm.2025.e00508_b1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0009-8981(60)90086-3","article-title":"Bile acids in man under normal and pathological conditions bile acids and steroids 73","volume":"5","author":"Sj\u00f6vall","year":"1960","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.plabm.2025.e00508_b2","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","article-title":"The continuing importance of bile acids in liver and intestinal disease","volume":"159","author":"Hofmann","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.plabm.2025.e00508_b3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plabm.2025.e00508_b4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00281-022-00935-7","article-title":"Bile acids and their receptors: modulators and therapeutic targets in liver inflammation","volume":"44","author":"Bertolini","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.plabm.2025.e00508_b5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/CS20220697","article-title":"Biological tuners to reshape the bile acid pool for therapeutic purposes in non-alcoholic fatty liver disease","volume":"137","author":"Gillard","year":"2023","journal-title":"Clin. Sci."},{"key":"10.1016\/j.plabm.2025.e00508_b6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-024-00914-3","article-title":"The changing metabolic landscape of bile acids \u2013 keys to metabolism and immune regulation","volume":"21","author":"Mohanty","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.plabm.2025.e00508_b7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1152\/physrev.00049.2019","article-title":"Molecular physiology of bile acid signaling in health, disease, and aging","volume":"101","author":"Perino","year":"2020","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.plabm.2025.e00508_b8","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1515\/cclm-2018-0741","article-title":"Fasting serum bile acids concentration is associated with insulin resistance independently of diabetes status","volume":"57","author":"Lee","year":"2019","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.plabm.2025.e00508_b9","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1210\/jc.2017-01397","article-title":"Bile acid alterations are associated with insulin resistance, but not with NASH, in obese subjects","volume":"102","author":"Legry","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.plabm.2025.e00508_b10","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.2337\/db13-0639","article-title":"Human insulin resistance is associated with increased plasma levels of 12\u03b1-hydroxylated bile acids","volume":"62","author":"Haeusler","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.plabm.2025.e00508_b11","doi-asserted-by":"crossref","first-page":"E864","DOI":"10.1152\/ajpendo.00644.2020","article-title":"Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women","volume":"320","author":"Mercer","year":"2021","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"10.1016\/j.plabm.2025.e00508_b12","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1210\/jc.2016-1607","article-title":"Postprandial plasma concentrations of individual bile acids and FGF-19 in patients with type 2 diabetes","volume":"101","author":"Sonne","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.plabm.2025.e00508_b13","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1210\/jc.2013-3367","article-title":"Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin","volume":"99","author":"Wewalka","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.plabm.2025.e00508_b14","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154042","article-title":"Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes","volume":"103","author":"Ch\u00e1vez-Talavera","year":"2020","journal-title":"Metab."},{"key":"10.1016\/j.plabm.2025.e00508_b15","doi-asserted-by":"crossref","first-page":"E1225","DOI":"10.1210\/jc.2015-2467","article-title":"Early increases in bile acids post Roux-en-Y gastric bypass are driven by insulin-sensitizing, secondary bile acids","volume":"100","author":"Albaugh","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.plabm.2025.e00508_b16","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/liv.15030","article-title":"Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus","volume":"41","author":"Jung","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.plabm.2025.e00508_b17","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut."},{"key":"10.1016\/j.plabm.2025.e00508_b18","first-page":"67","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","author":"Puri","year":"2018","journal-title":"Hepatol."},{"key":"10.1016\/j.plabm.2025.e00508_b19","article-title":"NASH-related increases in plasma bile acid levels depend on insulin resistance","volume":"3","author":"Grzych","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.plabm.2025.e00508_b20","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/oby.22627","article-title":"Ratio of conjugated chenodeoxycholic to muricholic acids is associated with severity of nonalcoholic steatohepatitis","volume":"27","author":"Chen","year":"2019","journal-title":"Obes."},{"key":"10.1016\/j.plabm.2025.e00508_b21","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154457","article-title":"Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression","volume":"116","author":"Nimer","year":"2021","journal-title":"Metab."},{"key":"10.1016\/j.plabm.2025.e00508_b22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MPG.0000000000000774","article-title":"Serum bile acid levels in children with nonalcoholic fatty liver disease","volume":"61","author":"Jahnel","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.plabm.2025.e00508_b23","article-title":"Analysis of the serum bile acid composition for differential diagnosis in patients with liver disease","volume":"2015","author":"Sugita","year":"2015","journal-title":"Gastroenterol. Res. Pr."},{"key":"10.1016\/j.plabm.2025.e00508_b24","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/acs.jproteome.0c00852","article-title":"Bile acid profiles are distinct among patients with different etiologies of chronic liver disease","volume":"20","author":"Sang","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.plabm.2025.e00508_b25","first-page":"13","article-title":"Association of serum and fecal bile acid patterns with liver fibrosis in biopsy-proven nonalcoholic fatty liver disease: An observational study","author":"Kasai","year":"2022","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.plabm.2025.e00508_b26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/apt.16948","article-title":"Circulating bile acid concentrations and non-alcoholic fatty liver disease in Guatemala","volume":"56","author":"Rivera-Andrade","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.plabm.2025.e00508_b27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/00365513.2022.2151508","article-title":"Efficacy of bile acid profiles in diagnosing and staging of alcoholic liver disease","volume":"83","author":"Zhang","year":"2023","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"10.1016\/j.plabm.2025.e00508_b28","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/acs.jproteome.1c00104","article-title":"Serum bile acid profiles improve clinical prediction of nonalcoholic fatty liver in T2DM patients","volume":"20","author":"Wu","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.plabm.2025.e00508_b29","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1007\/s10620-015-3776-8","article-title":"Altered bile acid metabolome in patients with nonalcoholic steatohepatitis","volume":"60","author":"Ferslew","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.plabm.2025.e00508_b30","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/ijc.33885","article-title":"Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma","volume":"150","author":"Stepien","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.plabm.2025.e00508_b31","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/ijc.33051","article-title":"Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies","volume":"147","author":"Petrick","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.plabm.2025.e00508_b32","first-page":"13","article-title":"Association between pre-diagnostic serum bile acids and hepatocellular carcinoma: The Singapore Chinese health study","author":"Thomas","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.plabm.2025.e00508_b33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193824","article-title":"Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans","volume":"13","author":"Luo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.plabm.2025.e00508_b34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105775","article-title":"Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls","volume":"205","author":"Zhang","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.plabm.2025.e00508_b35","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/djz166","article-title":"Prediagnostic plasma bile acid levels and colon cancer risk: A prospective study","volume":"112","author":"K\u00fchn","year":"2020","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"10.1016\/j.plabm.2025.e00508_b36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-017-1297-5","article-title":"Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer\u2019s disease","volume":"14","author":"Marksteiner","year":"2017","journal-title":"Metabolomics"},{"key":"10.1016\/j.plabm.2025.e00508_b37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","article-title":"Altered bile acid profile associates with cognitive impairment in Alzheimer\u2019s disease\u2014An emerging role for gut microbiome","volume":"15","author":"MahmoudianDehkordi","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.plabm.2025.e00508_b38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jalz.2018.08.012","article-title":"Altered bile acid profile in mild cognitive impairment and alzheimer\u2019s disease: Relationship to neuroimaging and CSF biomarkers","volume":"15","author":"Nho","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.plabm.2025.e00508_b39","first-page":"13","article-title":"Alterations in circulating bile acids in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis","author":"Lai","year":"2023","journal-title":"Biomol."},{"key":"10.1016\/j.plabm.2025.e00508_b40","first-page":"100","article-title":"Use of bile acids as potential markers of liver dysfunction in humans: A systematic review","author":"Azer","year":"2021","journal-title":"Med."},{"key":"10.1016\/j.plabm.2025.e00508_b41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jchromb.2012.05.015","article-title":"Bile acid profiling in human biological samples: Comparison of extraction procedures and application to normal and cholestatic patients","volume":"899","author":"Humbert","year":"2012","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.plabm.2025.e00508_b42","first-page":"3","article-title":"Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans","author":"Morville","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.plabm.2025.e00508_b43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","article-title":"Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study","volume":"44","author":"Trottier","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.plabm.2025.e00508_b44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijgo.2013.02.015","article-title":"Primary bile acids as potential biomarkers for the clinical grading of intrahepatic cholestasis of pregnancy","volume":"122","author":"Chen","year":"2013","journal-title":"Int. J. Gynecol. Obs."},{"key":"10.1016\/j.plabm.2025.e00508_b45","doi-asserted-by":"crossref","first-page":"e22094","DOI":"10.1371\/journal.pone.0022094","article-title":"Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting","volume":"6","author":"Trottier","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.plabm.2025.e00508_b46","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/pr500920q","article-title":"Profiling of serum bile acids in a healthy Chinese population using UPLC\u2013MS\/MS","volume":"14","author":"Xie","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.plabm.2025.e00508_b47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jchromb.2013.10.019","article-title":"The profile of bile acids and their sulfate metabolites in human urine and serum","volume":"942\u2013943","author":"Bathena","year":"2013","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.plabm.2025.e00508_b48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0039-128X(83)90121-6","article-title":"Determination of sulfated and nonsulfated bile acids in serum by mass fragmentography","volume":"42","author":"Murata","year":"1983","journal-title":"Steroids"},{"key":"10.1016\/j.plabm.2025.e00508_b49","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.36.2.268","article-title":"Unconjugated secondary bile acids in the serum of patients with colorectal adenomas","volume":"36","author":"Bayerd\u00f6rffer","year":"1995","journal-title":"Gut."},{"key":"10.1016\/j.plabm.2025.e00508_b50","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1440-1746.1996.tb00064.x","article-title":"Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease","volume":"11","author":"Azer","year":"1996","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.plabm.2025.e00508_b51","first-page":"23","article-title":"Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis","author":"Dasarathy","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.plabm.2025.e00508_b52","first-page":"12","article-title":"Distinct postprandial bile acids responses to a high-calorie diet in men volunteers underscore metabolically healthy and unhealthy phenotypes","author":"Lamaziere","year":"2020","journal-title":"Nutr."},{"key":"10.1016\/j.plabm.2025.e00508_b53","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ijo.2016.46","article-title":"Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans","volume":"40","author":"Spinelli","year":"2016","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.plabm.2025.e00508_b54","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.clnu.2017.06.015","article-title":"Transhepatic bile acid kinetics in pigs and humans","volume":"37","author":"Eggink","year":"2018","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.plabm.2025.e00508_b55","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.clnu.2014.09.018","article-title":"Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study","volume":"34","author":"Giorgi","year":"2015","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.plabm.2025.e00508_b56","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1007\/s00216-015-8853-5","article-title":"Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na+-taurocholate cotransporting polypeptide inhibitor","volume":"407","author":"Haag","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.plabm.2025.e00508_b57","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1194\/jlr.D028803","article-title":"Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method","volume":"53","author":"Garc\u00eda-Ca\u00f1averas","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plabm.2025.e00508_b58","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1515\/CCLM.2003.247","article-title":"Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: A simple and rapid one-step method","volume":"41","author":"Tagliacozzi","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.plabm.2025.e00508_b59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0009-8981(87)90446-3","article-title":"Diagnostic sensitivity of fasting and postprandial serum bile acids determined by different methods","volume":"162","author":"Mannes","year":"1987","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.plabm.2025.e00508_b60","first-page":"105","article-title":"Longitudinal profiles of 15 serum bile acids in patients with intrahepatic cholestasis of pregnancy","author":"Tribe","year":"2010","journal-title":"Off. J. Am. Coll. Gastroenterol. \u2014 ACG."},{"key":"10.1016\/j.plabm.2025.e00508_b61","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3109\/00365528209181093","article-title":"Postprandial serum concentration of individual bile acids in man","volume":"17","author":"Ewerth","year":"1982","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.plabm.2025.e00508_b62","unstructured":"\u00d6mr\u00fcm Aydin, A. Wahlstr\u00f6m, PA. de Jonge, A.S. Meijnikman, W. Sj\u00f6l, L. Olsson, et al., An integrated analysis of bile acid metabolism in humans with severe obesity, Hepatology 9900."},{"key":"10.1016\/j.plabm.2025.e00508_b63","doi-asserted-by":"crossref","first-page":"52775","DOI":"10.18632\/oncotarget.17188","article-title":"Middle-distance running acutely influences the concentration and composition of serum bile acids: Potential implications for cancer risk?","volume":"8","author":"Danese","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.plabm.2025.e00508_b64","first-page":"7","article-title":"Metabolomic profiling of bile acids in clinical and experimental samples of Alzheimer\u2019s disease","author":"Pan","year":"2017","journal-title":"Metab."},{"key":"10.1016\/j.plabm.2025.e00508_b65","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/gut.18.8.606","article-title":"Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids","volume":"18","author":"Angelin","year":"1977","journal-title":"Gut"},{"key":"10.1016\/j.plabm.2025.e00508_b66","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0009-8981(87)90231-2","article-title":"Quantitation of serum bile acids by isotope dilution with 13c-labelled homologs","volume":"162","author":"Stellaard","year":"1987","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.plabm.2025.e00508_b67","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0016-5085(85)80144-X","article-title":"Serum concentrations of ursodeoxycholic acid in portal venous and systemic venous blood of fasting humans as determined by isotope dilution\u2014Mass spectrometry","volume":"88","author":"Euverth","year":"1985","journal-title":"Gastroenterol."},{"key":"10.1016\/j.plabm.2025.e00508_b68","doi-asserted-by":"crossref","first-page":"569","DOI":"10.5604\/01.3001.0010.0294","article-title":"Sensitivity and specificity of biochemical tests for diagnosis of intrahepatic cholestasis of pregnancy","volume":"16","author":"Jurate","year":"2017","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.plabm.2025.e00508_b69","article-title":"In search of an accurate evaluation of intrahepatic cholestasis of pregnancy","author":"Martinefski","year":"2012","journal-title":"Sci."},{"key":"10.1016\/j.plabm.2025.e00508_b70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0925-4439(96)00030-0","article-title":"Concentration of unsulfated lithocholic acid in portal and systemic venous plasma: evidence that lithocholic acid does not down regulate the hepatic cholesterol 7\u03b1-hydroxylase activity in gallstone patients","volume":"1317","author":"Einarsson","year":"1996","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.plabm.2025.e00508_b71","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI110668","article-title":"Hepatic uptake of bile acids in man: fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum","volume":"70","author":"Angelin","year":"1982","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.plabm.2025.e00508_b72","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0016-5085(19)31517-3","article-title":"Individual bile acids in portal venous and systemic blood serum of fasting man","volume":"73","author":"Ahlberg","year":"1977","journal-title":"Gastroenterol."},{"key":"10.1016\/j.plabm.2025.e00508_b73","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.1840050423","article-title":"Portal venous bile acids in cholesterol gallstone disease: Effect of treatment with chenodeoxycholic and cholic acids","volume":"5","author":"Einarsson","year":"1985","journal-title":"Hepatol."},{"key":"10.1016\/j.plabm.2025.e00508_b74","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-8278(05)80401-5","article-title":"Serum bile acids and cholestasis in alcoholic hepatitis. Relationship with usual liver tests and histological features","volume":"21","author":"Trinchet","year":"1994","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plabm.2025.e00508_b75","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1194\/jlr.D047506","article-title":"A simple and accurate HPLC method for fecal bile acid profile in healthy and cirrhotic subjects: validation by GC-MS and LC-MS[S]","volume":"55","author":"Kakiyama","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plabm.2025.e00508_b76","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1007\/s00216-017-0489-1","article-title":"Factors affecting separation and detection of bile acids by liquid chromatography coupled with mass spectrometry in negative mode","volume":"409","author":"Yin","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.plabm.2025.e00508_b77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123976","article-title":"Determination of bile acids in serum of pigs exposed to polychlorinated biphenyls by liquid chromatography-mass spectrometry","volume":"1232","author":"Narduzzi","year":"2024","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.plabm.2025.e00508_b78","first-page":"2022","article-title":"Bile acid detection techniques and bile acid-related diseases","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.plabm.2025.e00508_b79","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00216-024-05668-0","article-title":"Rapid quantification of murine bile acids using liquid chromatography-tandem mass spectrometry","volume":"417","author":"Hermeling","year":"2025","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.plabm.2025.e00508_b80","series-title":"Analysis of Bile Acids","first-page":"837","article-title":"10","author":"Sj\u00f6vall","year":"2010"},{"key":"10.1016\/j.plabm.2025.e00508_b81","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/ac503816u","article-title":"Metabolic profiling of bile acids in human and mouse blood by LC\u2013MS\/MS in combination with phospholipid-depletion solid-phase extraction","volume":"87","author":"Han","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.plabm.2025.e00508_b82","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.jchromb.2009.09.038","article-title":"Rapid quantification of bile acids and their conjugates in serum by liquid chromatography\u2013tandem mass spectrometry","volume":"877","author":"Scherer","year":"2009","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.plabm.2025.e00508_b83","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00216-016-0048-1","article-title":"Rapid analysis of bile acids in different biological matrices using LC-ESI-MS\/MS for the investigation of bile acid transformation by mammalian gut bacteria","volume":"409","author":"Wegner","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.plabm.2025.e00508_b84","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1194\/jlr.RA119000311","article-title":"Quantification of bile acids: a mass spectrometry platform for studying gut microbe connection to metabolic diseases[S]","volume":"61","author":"Choucair","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plabm.2025.e00508_b85","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1021\/acs.analchem.5b01556","article-title":"Bile acid profiling and quantification in biofluids using ultra-performance liquid chromatography tandem mass spectrometry","volume":"87","author":"Sarafian","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.plabm.2025.e00508_b86","series-title":"An Improved Reverse Phase LC-MS\/MS Method for the Measurement of Bile Acids in Biological Samples","author":"Morlacchi","year":"2021"},{"key":"10.1016\/j.plabm.2025.e00508_b87","series-title":"Sciex","article-title":"Quantitative analysis and structural characterization of bile acids using the ZenoTOF 7600 system","author":"Sayers","year":"2024"},{"key":"10.1016\/j.plabm.2025.e00508_b88","series-title":"The Scientist","article-title":"Unraveling the role of bile acids in human health","author":"Horvath","year":"2025"},{"key":"10.1016\/j.plabm.2025.e00508_b89","first-page":"9","article-title":"Separation of serum and plasma proteins for in-depth proteomic analysis","author":"Paul","year":"2022","journal-title":"Sep."},{"key":"10.1016\/j.plabm.2025.e00508_b90","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1021\/acs.jproteome.1c00935","article-title":"Serum or plasma (and which plasma), that is the question","volume":"21","author":"Vignoli","year":"2022","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.plabm.2025.e00508_b91","doi-asserted-by":"crossref","first-page":"e21230","DOI":"10.1371\/journal.pone.0021230","article-title":"Differences between human plasma and serum metabolite profiles","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.plabm.2025.e00508_b92","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1046\/j.1523-1755.1998.00086.x","article-title":"Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a)","volume":"54","author":"Kronenberg","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.plabm.2025.e00508_b93","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1007\/s00216-018-1127-2","article-title":"Proteins and antibodies in serum, plasma, and whole blood\u2014size characterization using asymmetrical flow field-flow fractionation (AF4)","volume":"410","author":"Leeman","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.plabm.2025.e00508_b94","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1007\/s00216-014-8019-x","article-title":"Quantification of 33 antidepressants by LC-MS\/MS\u2014comparative validation in whole blood, plasma, and serum","volume":"406","author":"Montenarh","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.plabm.2025.e00508_b95","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.talanta.2013.03.048","article-title":"Ion suppression; a critical review on causes, evaluation, prevention and applications","volume":"115","author":"Furey","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.plabm.2025.e00508_b96","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24279","article-title":"A simple and reliable bile acid assay in human serum by LC-MS\/MS","volume":"36","author":"Shen","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.plabm.2025.e00508_b97","first-page":"10","article-title":"Development and validation of a highly sensitive LC-MS\/MS method for the analysis of bile acids in serum, plasma, and liver tissue samples","author":"G\u00f3mez","year":"2020","journal-title":"Metab."},{"key":"10.1016\/j.plabm.2025.e00508_b98","series-title":"Rapid improvements for LC\u2013MS\/MS analysis using the new phree phospholipid removal plates","author":"Rummel","year":"2012"},{"key":"10.1016\/j.plabm.2025.e00508_b99","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1373\/jalm.2016.020537","article-title":"Inter-laboratory robustness of next-generation bile acid study in mice and humans: International ring trial involving 12 laboratories","volume":"1","author":"Pham","year":"2016","journal-title":"J. Appl. Lab. Med."}],"container-title":["Practical Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352551725000617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352551725000617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T16:10:07Z","timestamp":1765469407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352551725000617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":99,"alternative-id":["S2352551725000617"],"URL":"https:\/\/doi.org\/10.1016\/j.plabm.2025.e00508","relation":{},"ISSN":["2352-5517"],"issn-type":[{"value":"2352-5517","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards the clinical use of peripheral bile acids: Recommendations to limit their preanalytical and analytical sources of variability","name":"articletitle","label":"Article Title"},{"value":"Practical Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plabm.2025.e00508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"e00508"}}